Cannabis contains a seemingly unique class of chemicals, the cannabinoids, of which more than 60 have been described, but only a few are psychoactive. Cannabinoids are produced in specialized epidermal glands, which differ notably in distribution on different organs of the plant (high concentrations occur on the upper surface of the young leaves and young twigs, on the tepals, stamens, and especially on the perigonal bract). Given this distribution, the glands would seem to be protective of young and reproductive above-ground tissues (the roots lack glands). Two classes of epidermal glands occur—stalked and sessile (Fig. 8), but in either case the glandular cells are covered by a sheath under which resin is accumulated, until the sheath ruptures, releasing resin on the surface. The resin is a sticky mixture of cannabinoids and a variety of terpenes. The characteristic odor of the plant is due to the abundant terpenes, which are not psychoactive. The more important cannabinoids are shown in Fig. 9. In the plant the cannabinoids exist predominantly in the form of carboxylic acids, which decarboxylate with time or when heated. Delta-9-tetrahydrocannabinol (D9-THC, or simply THC) is the predominant psychoactive component. Other THC isomers also occur, particularly D8-THC, which is also psychoactive. Technically, the euphoric psychological effects of THC are best described by the word psychotomimetic. Cannabidiol (CBD) is the chief non-psychotomimetic cannabinoid. A THC concentration in marijuana of approximately 0.9% has been suggested as a practical minimum level to achieve the (illegal) intoxicant effect, but CBD (the predominant cannabinoid of fiber and oilseed varieties) antagonizes (i.e. reduces) the effects of THC (Grotenhermen and Karus 1998). Concentrations of 0.3% to 0.9% are considered to have “only a small drug potential” (Grotenhermen and Karus 1998). Some cannabinoid races have been described, notably containing cannabichromene (particularly in high-THC forms) and cannabigerol monomethyl ether (in some Asian strains). The biosynthetic pathways of the cannabinoids are not yet satisfactorily elucidated, although the scheme shown in Fig. 10 is commonly accepted. At least in some strains, THC is derived from cannabigerol, while in others it may be derived from CBD. CBN and D8-THC are considered to be degradation products or analytical artifacts (Pate 1998a).
No ongoing clinical trials of Cannabis as a treatment for cancer in humans were identified in a PubMed search. The only published trial of any cannabinoid in patients with cancer is a small pilot study of intratumoral injection of delta-9-THC in patients with recurrent glioblastoma multiforme, which demonstrated no significant clinical benefit.[19,20] In a trial (NCT02255292) conducted in Israel, oral cannabidiol (CBD) was investigated as a single salvage agent for recurrent solid tumors. The study was projected to be completed in 2015; however, no results have been published. A small exploratory phase II study (GWCA1208 Part A [NCT01812603]) was conducted in the United Kingdom that used nabiximols, a 1:1 ratio of THC:CBD in a Cannabis-based medicinal extract oromucosal spray, in conjunction with temozolomide in treating patients with recurrent glioblastoma multiforme. The study enrolled 21 patients. Final results have not been published.

Cannabis sativa is extremely unusual in the diversity of products for which it is or can be cultivated. Popular Mechanics magazine (1938) touted hemp as “the new billion dollar crop,” stating that it “can be used to produce more than 25,000 products, ranging from dynamite to Cellophane.” Table 1 presents the principal products for which the species is cultivated in Europe, all of which happen to be based on fiber. This presentation stresses the products that hold the most promise for North America, which also include a considerable range of oilseed applications (Table 2; Fig. 1).
Essential (volatile) oil in hemp is quite different from hempseed oil. Examples of commercial essential oil product products are shown in Fig. 42. The essential oil is a mixture of volatile compounds, including monoterpenes, sesquiterpenes, and other terpenoid-like compounds that are manufactured in the same epidermal glands in which the resin of Cannabis is synthesized (Meier and Mediavilla 1998). Yields are very small—about 10 L/ha (Mediavilla and Steinemann 1997), so essential oil of C. sativa is expensive, and today is simply a novelty. Essential oil of different strains varies considerably in odor, and this may have economic importance in imparting a scent to cosmetics, shampoos, soaps, creams, oils, perfumes, and foodstuffs. Switzerland has been a center for the production of essential oil for the commercial market. Narcotic strains tend to be more attractive in odor than fiber strains, and because they produce much higher numbers of flowers than fiber strains, and the (female) floral parts provide most of the essential oil, narcotic strains are naturally adapted to essential oil production. Switzerland has permitted strains with higher THC content to be grown than is allowed in other parts of the world, giving the country an advantage with respect to the essential oil market. However, essential oil in the marketplace has often been produced from low-THC Cannabis, and the THC content of essential oil obtained by steam distillation can be quite low, producing a product satisfying the needs for very low THC levels in food and other commercial goods. The composition of extracted essential oil is quite different from the volatiles released around the fresh plant (particularly limonene and alpha-pinene), so that a pleasant odor of the living plant is not necessarily indicative of a pleasant-smelling essential oil. Essential oil has been produced in Canada by Gen-X Research Inc., Regina. The world market for hemp essential oil is very limited at present, and probably also has limited growth potential.
I suffer fr migraines. Currently having Botox injections every three months for the last three years. This has helped went fr 24 to 30 migraines a month to 6 to 8 , now I'm back up to 14 to 20 a month. My doctor thought CBD oil might help. I have also started having anxiety attacks for a year now. I'm really confused with the dosages. Any thoughts would b helpful
Hemp rope was used in the age of sailing ships, though the rope had to be protected by tarring, since hemp rope has a propensity for breaking from rot, as the capillary effect of the rope-woven fibers tended to hold liquid at the interior, while seeming dry from the outside.[42] Tarring was a labor-intensive process, and earned sailors the nickname "Jack Tar". Hemp rope was phased out when Manila, which does not require tarring, became widely available. Manila is sometimes referred to as Manila hemp, but is not related to hemp; it is abacá, a species of banana.
The importation and movement of hemp seeds and plants is restricted under federal law. According to the Statement of Principles on Industrial Hemp (81 Federal Register (FR) 53395) issued by the U.S. Department of Agriculture, U.S. Drug Enforcement Administration, and U.S. Food and Drug Administration, "industrial hemp plants and seeds may not be transported across State lines." For more information, contact the U.S. Drug Enforcement Administration.
There are ways to strain dangerous contaminants out of raw hemp paste. And most companies stand behind their quality and safety procedures. “We continuously test all our products ... to ensure our consumers get the levels of natural constituents they expect from the quality hemp stalk oil they purchase,” HempMedsPx states on its web site. “Additionally, all our products are tested for safety, to ensure there are no solvents, heavy metals, or other potentially harmful materials in our oil. Because we take these steps, we are always confident in our products, and you can be too.”